| abstract |
The invention relates to glucopyranosyloxypyrazole derivatives or pharmaceutically acceptable salts thereof which exhibit inhibitory activity on human SGLT2 and useful as agents for the prophylaxis or treatment of diabetes, diabetic complications or obesity. The invention also relates to pharmaceutical compositions which include said derivatives as well as to their intermediates. The derivatives are represented by the general formula wherein R1 represents a hydrogen atom or a lower alkyl group, one of Q1 and T1 represents a group of the formula while the other is a lower alkyl group or a halo (lower alkyl) group; R2 is a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a halo (lower alkyl) group or a halogen atom. |